Market Research Life Sciences Market Research Medical Devices Market Research Neurology Devices Market Research

Neurosurgical Products Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

Best Price Guarantee Length Publisher Published Date SKU
from $4,000 158 Pages GlobalData May, 2023 GBDT18015722
Best Price Guarantee
Price from $4,000
Length 158 Pages
Publisher GlobalData
Published Date May, 2023
SKU GBDT18015722

Neurosurgical Products Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update


Summary

GlobalData's Medical Devices sector report, “Neurosurgical Products Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Neurosurgical Products pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.Neurosurgical Products comprises of Dura Substitutes, Neuroendoscopes and Neurosurgical Drills.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Neurosurgical Products under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Neurosurgical Products and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Neurosurgical Products under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


    • 2 Table of Contents
    1 About GlobalData
    2 Table of Contents
    2.1 List of Tables
    2.2 List of Figures
    3 Introduction
    3.1 Neurosurgical Products Overview
    4 Products under Development
    4.1 Neurosurgical Products - Pipeline Products by Stage of Development
    4.2 Neurosurgical Products - Pipeline Products by Segment
    4.3 Neurosurgical Products - Pipeline Products by Territory
    4.4 Neurosurgical Products - Pipeline Products by Regulatory Path
    4.5 Neurosurgical Products - Pipeline Products by Estimated Approval Date
    4.6 Neurosurgical Products - Ongoing Clinical Trials
    5 Neurosurgical Products - Pipeline Products under Development by Companies
    5.1 Neurosurgical Products Companies - Pipeline Products by Stage of Development
    5.2 Neurosurgical Products – Companies Pipeline Products by Stage of Development
    6 Neurosurgical Products Companies and Product Overview
    6.1 Alcyone Therapeutics Inc Company Overview
    6.1.1 Alcyone Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.2 Aleva Neurotherapeutics SA Company Overview
    6.2.1 Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
    6.3 Anatomics Pty Ltd Company Overview
    6.3.1 Anatomics Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
    6.4 Augusta University Company Overview
    6.4.1 Augusta University Pipeline Products & Ongoing Clinical Trials Overview
    6.5 Axion BioSystems Inc Company Overview
    6.5.1 Axion BioSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.6 AxoGen Corp Company Overview
    6.6.1 AxoGen Corp Pipeline Products & Ongoing Clinical Trials Overview
    6.7 Beijing Biosis Healing Biological Technology Co Ltd Company Overview
    6.7.1 Beijing Biosis Healing Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
    6.8 Bendit Technologies Ltd Company Overview
    6.8.1 Bendit Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
    6.9 Biocircuit Technologies Inc Company Overview
    6.9.1 Biocircuit Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.10 C2C Development, LLC Company Overview
    6.10.1 C2C Development, LLC Pipeline Products & Ongoing Clinical Trials Overview
    6.11 Carnegie Mellon University Company Overview
    6.11.1 Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview
    6.12 Carthera SAS Company Overview
    6.12.1 Carthera SAS Pipeline Products & Ongoing Clinical Trials Overview
    6.13 Cizeta Surgical Company Overview
    6.13.1 Cizeta Surgical Pipeline Products & Ongoing Clinical Trials Overview
    6.14 Cornell University Company Overview
    6.14.1 Cornell University Pipeline Products & Ongoing Clinical Trials Overview
    6.15 Elite Surgical Supplies (Pty) Ltd Company Overview
    6.15.1 Elite Surgical Supplies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview
    6.16 Harvard University Company Overview
    6.16.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview
    6.17 Imperial College London Company Overview
    6.17.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
    6.18 InSightec Ltd Company Overview
    6.18.1 InSightec Ltd Pipeline Products & Ongoing Clinical Trials Overview
    6.19 Integra LifeSciences Holdings Corp Company Overview
    6.19.1 Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview
    6.20 International HIFU Company Overview
    6.20.1 International HIFU Pipeline Products & Ongoing Clinical Trials Overview
    6.21 InVivo Therapeutics Corp Company Overview
    6.21.1 InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview
    6.22 JetGuide Ltd Company Overview
    6.22.1 JetGuide Ltd Pipeline Products & Ongoing Clinical Trials Overview
    6.23 Johns Hopkins University Company Overview
    6.23.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
    6.24 KARL STORZ SE & Co KG Company Overview
    6.24.1 KARL STORZ SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview
    6.25 Kerecis ehf Company Overview
    6.25.1 Kerecis ehf Pipeline Products & Ongoing Clinical Trials Overview
    6.26 Kuros Biosciences AG Company Overview
    6.26.1 Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview
    6.27 LeMaitre Vascular Inc Company Overview
    6.27.1 LeMaitre Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.28 Lumendo AG Company Overview
    6.28.1 Lumendo AG Pipeline Products & Ongoing Clinical Trials Overview
    6.29 Massachusetts Institute of Technology Company Overview
    6.29.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
    6.30 Mayo Clinic Company Overview
    6.30.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
    6.31 Medtronic Plc Company Overview
    6.31.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
    6.32 Microsurgical Innovations Inc Company Overview
    6.32.1 Microsurgical Innovations Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.33 MRC Systems GmbH Company Overview
    6.33.1 MRC Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview
    6.34 Nanonerve Inc. Company Overview
    6.34.1 Nanonerve Inc. Pipeline Products & Ongoing Clinical Trials Overview
    6.35 Neuraptive Therapeutics Inc Company Overview
    6.35.1 Neuraptive Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.36 NeuroOne Medical Technologies Corp Company Overview
    6.36.1 NeuroOne Medical Technologies Corp Pipeline Products & Ongoing Clinical Trials Overview
    6.37 Nurami Medical Ltd Company Overview
    6.37.1 Nurami Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
    6.38 Orthocell Ltd Company Overview
    6.38.1 Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview
    6.39 PediaWorks Inc Company Overview
    6.39.1 PediaWorks Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.40 Replication Medical Inc Company Overview
    6.40.1 Replication Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
    6.41 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview
    6.41.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview
    6.42 Scivita Medical Technology Co Ltd Company Overview
    6.42.1 Scivita Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
    6.43 Senzime AB Company Overview
    6.43.1 Senzime AB Pipeline Products & Ongoing Clinical Trials Overview
    6.44 Skull Base Institute Company Overview
    6.44.1 Skull Base Institute Pipeline Products & Ongoing Clinical Trials Overview
    6.45 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
    6.45.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
    6.46 The Swedish Neuroscience Institute Company Overview
    6.46.1 The Swedish Neuroscience Institute Pipeline Products & Ongoing Clinical Trials Overview
    6.47 Department of Veterans Affairs Company Overview
    6.47.1 Department of Veterans Affairs Pipeline Products & Ongoing Clinical Trials Overview
    6.48 University of Colorado Company Overview
    6.48.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
    6.49 University of Maryland Baltimore Company Overview
    6.49.1 University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview
    6.50 University of South Florida Company Overview
    6.50.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
    6.51 University of Texas Medical Branch at Galveston Company Overview
    6.51.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
    6.52 University of Utah Company Overview
    6.52.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview
    6.53 Vanderbilt University Company Overview
    6.53.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview
    6.54 Xylos Corporation Company Overview
    6.54.1 Xylos Corporation Pipeline Products & Ongoing Clinical Trials Overview
    7 Neurosurgical Products- Recent Developments
    7.1 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
    7.2 May 04, 2023: Cardinal Health reports third quarter fiscal year 2023 results and raises fiscal year 2023 non-gaap eps guidance
    7.3 May 01, 2023: FAU and Insightec partner to use focused ultrasound to treat neurological disorders
    7.4 Apr 28, 2023: Japan Medical Dynamic Marketing announces summary of consolidated financial results for the fiscal year ended March 2023
    7.5 Apr 27, 2023: OssDsign notice to attend the annual general meeting
    7.6 Apr 19, 2023: BioArctic's Invitation to presentation of first quarter report for January - March 2023 on April 27
    7.7 Apr 12, 2023: Medtronic has a layoff in California
    7.8 Mar 28, 2023: Stryker announces Annual Meeting of Shareholders
    7.9 Mar 24, 2023: American Shared Hospital Services Reports Fourth Quarter and Year End 2022 Financial Results
    7.10 Mar 16, 2023: Surgalign to Host its 2023 Annual Meeting of Shareholders on June 1, 2023
    7.11 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
    7.12 Mar 08, 2023: UCSF Health Appoints Two Prominent Healthcare Executives to Senior Leadership Positions
    7.13 Mar 06, 2023: Oonpoint to present its augmented reality platform technology at the 2023 Canaccord Genuity Musculoskeletal Conference
    7.14 Mar 03, 2023: Nation's first pediatric hybrid intraoperative MRI neurosurgery suite opens at Children's Minnesota
    7.15 Feb 10, 2023: Carl Zeiss Meditec achieves further revenue growth in First quarter 2022/23
    7.16 Feb 02, 2023: Cardinal Health Reports Second Quarter Fiscal Year 2023 Results and Raises Fiscal Year 2023 Non-GAAP EPS Guidance
    7.17 Jan 31, 2023: Japan Medical Dynamic Marketing Announces Summary of Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 2023
    7.18 Jan 10, 2023: OssDsign Catalyst 1cc is now launched and available in the U.S. market
    7.19 Jan 09, 2023: NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2022 Revenue and Appoints Dr. Uri Geiger to Board of Directors
    7.20 Dec 19, 2022: Cardinal Health Names Aaron Alt Chief Financial Officer
    7.21 Dec 07, 2022: Cook Medical welcomes Dr. John A. Kaufman as Chief Medical Officer
    7.22 Nov 23, 2022: Medtronic Reports Quarterly Earnings
    7.23 Nov 22, 2022: OssDsign publishes Q3 2022 Interim Report
    7.24 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
    7.25 Nov 22, 2022: Mayo Clinic surgeon takes the wheel as Kwik Trip's new CEO
    7.26 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
    7.27 Oct 06, 2022: Integra LifeSciences appoints Harvinder Singh as Executive Vice President, President Of Co.''s International Business
    7.28 Oct 06, 2022: Integra LifeSciences Announces Key Executive Appointment
    7.29 Sep 30, 2022: Renishaw Annual Report 2022
    7.30 Sep 30, 2022: Natalie Caine named chief administrative officer at Mayo Clinic in Rochester
    7.31 Sep 16, 2022: Renishaw Preliminary announcement of results for the year ended 30 June 2022
    7.32 Sep 08, 2022: Cardinal Health Announces Pharmaceutical Segment Organizational Changes
    7.33 Sep 07, 2022: Medtronic to appear at September investor conferences
    7.34 Sep 05, 2022: Renishaw Register for the 2022 full-year results webcast
    7.35 Sep 01, 2022: American Shared Hospital Services Strengthens Management Team with Appointment of Peter Gaccione as Chief Operating Officer
    7.36 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results
    7.37 Aug 23, 2022: NeuroPace to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
    7.38 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results
    7.39 Aug 12, 2022: American Shared Hospital Services Reports 12.5% Period-over-Period Increase in Second Quarter 2022 Revenue
    7.40 Aug 11, 2022: Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2022
    7.41 Aug 11, 2022: NeuroPace Reports Second Quarter 2022 Financial Results and Provides a Business Update
    7.42 Aug 11, 2022: Precipio Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
    7.43 Aug 08, 2022: ClearPoint Neuro Announces Appointment of Mary McNamara-Cullinane as Vice President of Regulatory Affairs
    7.44 Aug 08, 2022: Precipio Announces Second Quarter Shareholder Update Call
    7.45 Aug 08, 2022: InVivo Therapeutics Holdings Announces Quarterly Report For the quarterly period ended June 30, 2022
    7.46 Aug 01, 2022: Cardinal Health Names Michelle Greene as Chief Information Officer
    7.47 Jul 28, 2022: Smith+Nephew Second Quarter and First Half 2022 Results
    7.48 Jul 21, 2022: NeuroPace to Report Second Quarter 2022 Financial Results on August 11, 2022
    7.49 Jul 12, 2022: Aspire & USF Pass $10M in ticket & donation revenue
    7.50 Jul 07, 2022: Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2022 on August 11
    7.51 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director
    7.52 Jun 20, 2022: MicroTransponder Appoints New CEO
    7.53 Jun 13, 2022: Keith Meadors Joins Precipio To Lead Its Products Division
    7.54 Jun 08, 2022: OssDsign announces that SEB has initiated research coverage of the company
    7.55 Jun 06, 2022: Altus Spine heads to Prague, Czech Republic, as Platinum Sponsors of the Society of University Neurosurgeons Annual Meeting
    8 Appendix
    8.1 Methodology
    8.2 About GlobalData
    8.3 Contact Us
    8.4 Disclaimer
    2.1 List of Tables
    Table 1: Neurosurgical Products - Pipeline Products by Stage of Development
    Table 2: Neurosurgical Products - Pipeline Products by Segment
    Table 3: Neurosurgical Products - Pipeline Products by Territory
    Table 4: Neurosurgical Products - Pipeline Products by Regulatory Path
    Table 5: Neurosurgical Products - Pipeline Products by Estimated Approval Date
    Table 6: Neurosurgical Products - Ongoing Clinical Trials
    Table 7: Neurosurgical Products Companies - Pipeline Products by Stage of Development
    Table 8: Neurosurgical Products – Companies Pipeline Products by Stage of Development
    Table 9: Alcyone Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 10: Next-Gen Chronic AMC - Product Status
    Table 11: Next-Gen Chronic AMC - Product Description
    Table 12: ThecaFlex DRx System - Product Status
    Table 13: ThecaFlex DRx System - Product Description
    Table 14: Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
    Table 15: spiderSTIM - Product Status
    Table 16: spiderSTIM - Product Description
    Table 17: Anatomics Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
    Table 18: DuraShield - Product Status
    Table 19: DuraShield - Product Description
    Table 20: Augusta University Pipeline Products & Ongoing Clinical Trials Overview
    Table 21: Surgical Instrument - Neurological Procedures - Product Status
    Table 22: Surgical Instrument - Neurological Procedures - Product Description
    Table 23: Axion BioSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 24: Microhook Based Nerve Tape Device - Product Status
    Table 25: Microhook Based Nerve Tape Device - Product Description
    Table 26: AxoGen Corp Pipeline Products & Ongoing Clinical Trials Overview
    Table 27: Axoguard HA+ Nerve Protector - Product Status
    Table 28: Axoguard HA+ Nerve Protector - Product Description
    Table 29: Beijing Biosis Healing Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
    Table 30: Dura Repair Mesh - Product Status
    Table 31: Dura Repair Mesh - Product Description
    Table 32: Bendit Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
    Table 33: Bendit21 Microcatheter - Product Status
    Table 34: Bendit21 Microcatheter - Product Description
    Table 35: Biocircuit Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 36: Nerve Tape - Product Status
    Table 37: Nerve Tape - Product Description
    Table 38: C2C Development, LLC Pipeline Products & Ongoing Clinical Trials Overview
    Table 39: NAViTECH Streamlined Device - Product Status
    Table 40: NAViTECH Streamlined Device - Product Description
    Table 41: Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview
    Table 42: Hydrosurgery System - Product Status
    Table 43: Hydrosurgery System - Product Description
    Table 44: Carthera SAS Pipeline Products & Ongoing Clinical Trials Overview
    Table 45: SonoCloud - 9 - Product Status
    Table 46: SonoCloud - 9 - Product Description
    Table 47: SonoCloud System - Product Status
    Table 48: SonoCloud System - Product Description
    Table 49: SonoProbe - Product Status
    Table 50: SonoProbe - Product Description
    Table 51: Carthera SAS - Ongoing Clinical Trials Overview
    Table 52: SonoCloud System - Safety and Efficacy of Blood Brain Barrier Opening with Implantable Device Sonocloud Combined with Nivolumab Used Alone or an Association with Ipilimumab in Brain Metastases from Patients with Malignant Melanoma
    Table 53: SonoCloud - 9 - Multisite Open-label Randomized Phase II Clinical Trial in Newly Diagnosed Glioblastoma Treated by Concurrent Temoradiation and Adjuvant Temozolomide +/- Ultrasound-induced Blood Brain Barrier Opening
    Table 54: SonoCloud - 9 - Phase 1 / 2 Trial of Blood-brain Barrier Opening With an Implantable Ultrasound Device SonoCloud-9 and Treatment with Albumin-bound Paclitaxel and Carboplatin in Patients With Recurrent Glioblastoma
    Table 55: SonoCloud - 9 - Phase I Trial Assessing the Safety of the Repeated Ultrasound-induced Opening of the Blood-brain Barrier in Pediatric Patients With Refractory Supra-tentorial Malignant Brain Tumors Before Chemotherapy Administration
    Table 56: Cizeta Surgical Pipeline Products & Ongoing Clinical Trials Overview
    Table 57: Skull Grip - Product Status
    Table 58: Skull Grip - Product Description
    Table 59: Cornell University Pipeline Products & Ongoing Clinical Trials Overview
    Table 60: Tightly-Focused Femtosecond Laser - Product Status
    Table 61: Tightly-Focused Femtosecond Laser - Product Description
    Table 62: Elite Surgical Supplies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview
    Table 63: CRANIAL SYSTEM - Product Status
    Table 64: CRANIAL SYSTEM - Product Description
    Table 65: Harvard University Pipeline Products & Ongoing Clinical Trials Overview
    Table 66: Safe Cranial Drilling Device - Product Status
    Table 67: Safe Cranial Drilling Device - Product Description
    Table 68: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
    Table 69: Catheter System - Product Status
    Table 70: Catheter System - Product Description
    Table 71: InSightec Ltd Pipeline Products & Ongoing Clinical Trials Overview
    Table 72: ExAblate Neuro - Product Status
    Table 73: ExAblate Neuro - Product Description
    Table 74: Exablate Neuro - Alzheimer’s Disease - Product Status
    Table 75: Exablate Neuro - Alzheimer’s Disease - Product Description
    Table 76: InSightec Ltd - Ongoing Clinical Trials Overview
    Table 77: ExAblate Neuro - A Clinical Study to Investigate the Safety and Efficacy of Exablate Neuro for glioblastoma treatment
    Table 78: ExAblate Neuro - A Clinical Trial to Evaluate the Safety and Efficacy of Staged Bilateral Exablate Treatment of Medication Refractory Essential Tremor
    Table 79: ExAblate Neuro - A Feasibility Clinical Trial of Exablate for Low Intensity Focused Ultrasound Neuromodulation in Patients with Opioid Use Disorder (OUD)
    Table 80: ExAblate Neuro - A Feasibility Study of MRgFUS in the Treatment of Therapy-Resistant Tremor-Related Patients with Low SDR Value
    Table 81: ExAblate Neuro - A Feasibility Study on the Safety and Preliminary Efficacy of Bilateral Subthalamotomy Using the ExAblate Transcranial System to Treat the Cardinal Motor Features of Parkinson's Disease
    Table 82: ExAblate Neuro - A Feasibility Study to Evaluate Safety and Initial Effectiveness of MR-Guided Focused Ultrasound Ablation Therapy in the Treatment of Focal Epilepsy
    Table 83: ExAblate Neuro - A Pilot Study for Brain Delivery of Cerezyme in Patients with Parkinson's Disease Using MR-guided Focused Ultrasound Induced Opening of the Blood-brain Barrier
    Table 84: ExAblate Neuro - A Pivotal Clinical Trial of the Management of the Medically-refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Idiopathic Parkinson's Disease with Unilateral Lesioning of the Globus Pallidum Using the ExAblate Neuro System
    Table 85: ExAblate Neuro - A Pivotal Study Evaluating the Efficacy of Exablate Neuro System in the Treatment of Patients with Primary Non-small Cell Lung Cancer: LIMITLESS
    Table 86: ExAblate Neuro - Assessment of Safety and Feasibility of Exablate Blood-brain Barrier Disruption (BBBD) with Microbubbles for the Treatment of Recurrent Glioblastoma (rGBM) in Subjects Undergoing Carboplatin Monotherapy
    Table 87: ExAblate Neuro - Assessment of Safety and Feasibility of ExAblate Blood-brain Barrier Disruption for the Treatment of High Grade Glioma in Patients Undergoing Standard Chemotherapy
    Table 88: ExAblate Neuro - Assessment of Safety and Feasibility of Exablate Blood-brain Barrier Disruption for the Treatment of High-grade Glioma in Patients Undergoing Standard Chemotherapy
    Table 89: ExAblate Neuro - Assessment of Safety and Feasibility of Exablate Blood-brain Barrier Open (BBB Open) with Microbubble Resonators for the Treatment of Recurrent Glioblastoma (rGBM) in Subjects Undergoing Carboplatin Monotherapy (Clinical Research for BBB Open)
    Table 90: ExAblate Neuro - Assessment of Safety and Feasibility of ExAblate Neuro System to Perform Auto-focusing Echo Imaging in Patients with Idiopathic Essential Tremor with Medication Refractory Tremor
    Table 91: ExAblate Neuro - Assessment of Safety and Feasibility of Exablate Neuro System to Perform Echo-Focusing Echo Imaging in Patients with Treatment-Resistant Neurologic and Psychiatric Indications
    Table 92: ExAblate Neuro - Phase 1 Clinical Trial for MR Guided Focused Ultrasound (FUS) Thalamotomy of Central Lateral Thalamic Nucleus for the Treatment of Medication-refractory Trigeminal Neuralgia
    Table 93: ExAblate Neuro - Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy for Pain Palliation in Head & Neck Cancer
    Table 94: ExAblate Neuro - Transcranial Ultrasound Therapy of Essential Tremor
    Table 95: Exablate Neuro - Alzheimer’s Disease - A Phase IIa Study to Evaluate the Safety and Efficacy of Blood-Brain Barrier (BBB) Opening Using Transcranial MR-guided Focused Ultrasound in Patients with Alzheimer's Disease
    Table 96: Exablate Neuro - Alzheimer’s Disease - Assessment of Safety and Efficacy of ExAblate Blood-brain Barrier Disruption for the Treatment of Patients with Probable Alzheimer's Disease
    Table 97: Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview
    Table 98: MAYFIELD Composite - Product Status
    Table 99: MAYFIELD Composite - Product Description
    Table 100: Next Generation DuraSeal - Product Status
    Table 101: Next Generation DuraSeal - Product Description
    Table 102: International HIFU Pipeline Products & Ongoing Clinical Trials Overview
    Table 103: High Intensity Focused Ultrasound System - Product Status
    Table 104: High Intensity Focused Ultrasound System - Product Description
    Table 105: InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview
    Table 106: Dural Graft - Product Status
    Table 107: Dural Graft - Product Description
    Table 108: JetGuide Ltd Pipeline Products & Ongoing Clinical Trials Overview
    Table 109: JetGuide System - Neuro - Product Status
    Table 110: JetGuide System - Neuro - Product Description
    Table 111: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
    Table 112: Minimally Invasive Focused Ultrasound Device - Product Status
    Table 113: Minimally Invasive Focused Ultrasound Device - Product Description
    Table 114: Radiex - Product Status
    Table 115: Radiex - Product Description
    Table 116: KARL STORZ SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview
    Table 117: Video Neuro-Endoscope - Product Status
    Table 118: Video Neuro-Endoscope - Product Description
    Table 119: Kerecis ehf Pipeline Products & Ongoing Clinical Trials Overview
    Table 120: Kerecis Omega3 Dura - Product Status
    Table 121: Kerecis Omega3 Dura - Product Description
    Table 122: Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview
    Table 123: Neuroseal - Cranial - Product Status
    Table 124: Neuroseal - Cranial - Product Description
    Table 125: LeMaitre Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 126: DuraSure - Product Status
    Table 127: DuraSure - Product Description
    Table 128: Lumendo AG Pipeline Products & Ongoing Clinical Trials Overview
    Table 129: Micro-Surgical Instrument - Product Status
    Table 130: Micro-Surgical Instrument - Product Description
    Table 131: Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
    Table 132: Magnetically Steerable Robot - Product Status
    Table 133: Magnetically Steerable Robot - Product Description
    Table 134: Ultrathin Endoscope - Product Status
    Table 135: Ultrathin Endoscope - Product Description
    Table 136: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
    Table 137: Minimally Invasive Neurology/Neurosurgery Device - Product Status
    Table 138: Minimally Invasive Neurology/Neurosurgery Device - Product Description
    Table 139: Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
    Table 140: Duratech BioRegeneration Matrix - Product Status
    Table 141: Duratech BioRegeneration Matrix - Product Description
    Table 142: Microsurgical Innovations Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 143: Biodegradable Nerve Conduit - Product Status
    Table 144: Biodegradable Nerve Conduit - Product Description
    Table 145: MRC Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview
    Table 146: Multilas - Product Status
    Table 147: Multilas - Product Description
    Table 148: Nanonerve Inc. Pipeline Products & Ongoing Clinical Trials Overview
    Table 149: Nanofibrous Dural Substitute - Product Status
    Table 150: Nanofibrous Dural Substitute - Product Description
    Table 151: Neuraptive Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 152: AxoBond - Product Status
    Table 153: AxoBond - Product Description
    Table 154: AxoTrim - Product Status
    Table 155: AxoTrim - Product Description
    Table 156: NeuroOne Medical Technologies Corp Pipeline Products & Ongoing Clinical Trials Overview
    Table 157: Percutaneous Paddle Lead Placement System - Product Status
    Table 158: Percutaneous Paddle Lead Placement System - Product Description
    Table 159: Nurami Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
    Table 160: Artifascia - Product Status
    Table 161: Artifascia - Product Description
    Table 162: Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview
    Table 163: Remplir - Product Status
    Table 164: Remplir - Product Description
    Table 165: PediaWorks Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 166: Neurosurgery Resector - Product Status
    Table 167: Neurosurgery Resector - Product Description
    Table 168: Replication Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
    Table 169: Neural Implant - Product Status
    Table 170: Neural Implant - Product Description
    Table 171: Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview
    Table 172: Craniotomy Suture Passer - Product Status
    Table 173: Craniotomy Suture Passer - Product Description
    Table 174: Scivita Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
    Table 175: Single-Use Neuro Videoscope - Product Status
    Table 176: Single-Use Neuro Videoscope - Product Description
    Table 177: Single-Use Neurosurgical Videoscope - Product Status
    Table 178: Single-Use Neurosurgical Videoscope - Product Description
    Table 179: Senzime AB Pipeline Products & Ongoing Clinical Trials Overview
    Table 180: TetraSens Pediatric - Product Status
    Table 181: TetraSens Pediatric - Product Description
    Table 182: Skull Base Institute Pipeline Products & Ongoing Clinical Trials Overview
    Table 183: MARVEL - Product Status
    Table 184: MARVEL - Product Description
    Table 185: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
    Table 186: Bovine Pericardium - Dura Substitute - Product Status
    Table 187: Bovine Pericardium - Dura Substitute - Product Description
    Table 188: Intracranial Electrode - Epilepsy Surgery - Product Status
    Table 189: Intracranial Electrode - Epilepsy Surgery - Product Description
    Table 190: The Swedish Neuroscience Institute Pipeline Products & Ongoing Clinical Trials Overview
    Table 191: MR-guided Focused Ultrasound System - Product Status
    Table 192: MR-guided Focused Ultrasound System - Product Description
    Table 193: U.S. Department of Veterans Affairs Pipeline Products & Ongoing Clinical Trials Overview
    Table 194: Implantable Device - Product Status
    Table 195: Implantable Device - Product Description
    Table 196: University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
    Table 197: Denver Surgical Corridor - Product Status
    Table 198: Denver Surgical Corridor - Product Description
    Table 199: University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview
    Table 200: Minimally Invasive Neurosurgical Intracranial Robot - Product Status
    Table 201: Minimally Invasive Neurosurgical Intracranial Robot - Product Description
    Table 202: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
    Table 203: Dural Knife With Protective Foot-Plate - Product Status
    Table 204: Dural Knife With Protective Foot-Plate - Product Description
    Table

    $4,000
    $8,000
    $12,000

    Research Assistance

    US: 800.298.5699
    Int'l: +1.240.747.3093
    Live help
    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Other tasks

    Cookie Settings